Stocks · News reference
QT Imaging Receives Israeli Regulatory Approval For Breast Acoustic CT Scanner Through February 2, 2028
Regulatory approval enables commercialization of QT Imaging's technology in Israel and supports expansion of clinical research collaborationsQT Imaging Holdings, Inc.(NASDAQ:QTI) ("QT Imaging" or the
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Craig-Hallum Initiates Coverage On QT Imaging Holdings with Buy Rating, Announces Price Target of $8
Craig-Hallum analyst Matthew Hewitt initiates coverage on QT Imaging Holdings (NASDAQ:QTI) with a Buy rating and announces Price Target of $8.
UPDATE: QT Imaging Holdings Q2 Adj. EPS $(0.19) Beats $(0.22) Estimate, Sales $7.435M Miss $7.600M Estimate
QT Imaging Holdings (NASDAQ:QTI) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.22) by 13.64 percent. This is a 54.76 percent increase over losses of $(0.42) per share
QT Imaging Holdings Affirms FY2026 Sales Guidance of $39.000M vs $39.200M Est
QT Imaging Holdings (NASDAQ:QTI) affirms FY2026 sales outlook from $39.000 million to $39.000 million vs $39.200 million estimate.